Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05493787 · ClinicalTrials.gov registry record · NA
Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 139,503
- Enrollment target
NCT05493787 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 139,503 participants.
The verdict
NCT05493787, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 139,503 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether messages that make it easy to schedule a flu shot appointment will increase flu shot rates in patients without an upcoming appointment. The study will also test which message versions and message timing are most effective for increasing flu vaccination.
Interventions
- BEHAVIORAL Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139,503 participants |
| Start Date | 2022-11-08 |
| Est. Completion | 2023-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05493787
The ClinicalTrials.gov registry entry for NCT05493787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139,503 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reminder is the first listed.
NCT05493787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05493787 about?
NCT05493787 is a clinical study titled "Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot". The purpose of this study is to test whether messages that make it easy to schedule a flu shot appointment will increase flu shot rates in patients without an upcoming appointment. The study will also test which message versions and message timing are most effective for increasing flu vaccination.
What is the current status of trial NCT05493787?
This trial is currently completed. It is a NA study. The enrollment target is 139,503 participants. The study started on 2022-11-08. Estimated completion is 2023-01-03.
What interventions are being tested in trial NCT05493787?
The interventions under investigation include: Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT05493787?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.